MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

 

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 01
02-02-2010
EHMT1 9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome.
Vs. 04
11-03-2012
EHMT1 9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome.
Vs. 05
26-12-2012
EHMT1 9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome.
Vs. 02
15-06-2009
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 03
23-12-2010
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 04
11-03-2012
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 06
10-05-2013
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 07
11-08-2015
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 08
28-06-2016
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 02
15-06-2009
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 03
23-12-2010
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 06
10-05-2013
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 07
11-08-2015
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 08
28-06-2016
PKHD1 Polycystic kidney disease, autosomal recessive (ARPKD)
Vs. 02
26-03-2009
15q11-13: UBE3A, GABRB3; 16p11; SHANK3 22q13 Autism-1
Vs. 03
11-08-2010
15q11-13: UBE3A, GABRB3; 16p11; SHANK3 22q13 Autism-1
Vs. 07
16-08-2013
15q11-13: UBE3A, GABRB3; 16p11; SHANK3 22q13 Autism-1
Vs. 08
11-08-2015
15q11-13: UBE3A, GABRB3; 16p11; SHANK3 22q13 Autism-1
Vs. 09
04-11-2016
15q11-13: UBE3A, GABRB3; 16p11; SHANK3 22q13 Autism-1
Vs. 01
15-03-2010
HFE, SLC40A1, TFR2, HFE2, HAMP Hereditary hemochromatosis (HH)
Vs. 05
08-03-2013
HFE, SLC40A1, TFR2, HFE2, HAMP Hereditary hemochromatosis (HH)
Vs. 06
24-05-2013
HFE, SLC40A1, TFR2, HFE2, HAMP Hereditary hemochromatosis (HH)
Vs. 07
11-08-2015
HFE, SLC40A1, TFR2, HFE2, HAMP Hereditary hemochromatosis (HH)
Vs. 08
01-04-2016
HFE, SLC40A1, TFR2, HFE2, HAMP Hereditary hemochromatosis (HH)
Vs. 02
14-07-2010
1q23 Migraine
Vs. 05 09-12-2012 1q23 Migraine
Vs. 06 13-08-2015 1q23 Migraine
Vs. 08 07-03-2017 1q23 Migraine
Vs. 01
26-11-2009
CLCN1, KCNJ2 Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome
Vs. 02
08-11-2011
CLCN1, KCNJ2 Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome
Vs. 03
09-12-2012
CLCN1, KCNJ2 Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome
Vs. 04
01-06-2015
CLCN1, KCNJ2 Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome
Vs. 05
04-03-2016
CLCN1, KCNJ2 Myotonia congenita, Thomsen's disease, Becker's disease, Andersen-Tawil syndrome
Vs. 03
25-03-2010
PKD1 Adult polycystic kidney disease
Vs. 04
11-07-2011
PKD1 Adult polycystic kidney disease
Vs. 06
01-03-2013
PKD1 Adult polycystic kidney disease
Vs. 08
30-03-2015
PKD1 Adult polycystic kidney disease
Vs. C1-01
08-03-2018
PKD1 Adult polycystic kidney disease
Vs. 03
25-03-2010
PKD2, PKD1 Adult polycystic kidney disease
Vs. 04
11-07-2011
PKD2, PKD1 Adult polycystic kidney disease
Vs. 06
01-03-2013
PKD2, PKD1 Adult polycystic kidney disease
Vs. 08
30-03-2015
PKD2, PKD1 Adult polycystic kidney disease
P353-A1 Vs. 01 22-11-2011 SH3TC2, NEFL, GDAP1, EGR2, SBF2, MTMR2, PRX Charcot-Marie-Tooth neuropathy type 4 (CMT4)
P353-A1 Vs. 02 09-12-2012 SH3TC2, NEFL, GDAP1, EGR2, SBF2, MTMR2, PRX Charcot-Marie-Tooth neuropathy type 4 (CMT4)
P353-A1 Vs. 04 05-11-2015 SH3TC2, NEFL, GDAP1, EGR2, SBF2, MTMR2, PRX Charcot-Marie-Tooth neuropathy type 4 (CMT4)
Vs. 01
03-01-2011
KIT, SNAI2 Piebaldism/KIT
Vs. 02
29-02-2012
KIT, SNAI2 Piebaldism/KIT
Vs. 03 09-12-2012 KIT, SNAI2 Piebaldism/KIT
Vs. 04 15-04-2015 KIT, SNAI2 Piebaldism/KIT
Vs. 01
27-07-2011
MCPH1, ASPM, CDK5RAP2, CENPJ, STIL Primary Microcephaly
Vs. 03
09-12-2012
MCPH1, ASPM, CDK5RAP2, CENPJ, STIL Primary Microcephaly
Vs. 05
08-09-2015
MCPH1, ASPM, CDK5RAP2, CENPJ, STIL Primary Microcephaly
Vs. 03
29-06-2011
22q11, 22q13 Subtelomeric screening
Vs. 06
01-03-2013
22q11, 22q13 Subtelomeric screening
Vs. 07
03-06-2015
22q11, 22q13 Subtelomeric screening
Vs. 02
03-03-2011
MODY 4; 6-10 Maturity-Onset Diabetes of the Young (MODY)
P357-A1 Vs. 03 15-03-2012 MODY 4; 6-10 Maturity-Onset Diabetes of the Young (MODY)
P357-A1 Vs. 04 12-02-2012 MODY 4; 6-10 Maturity-Onset Diabetes of the Young (MODY)
P357-A2 Vs. 05 12-08-2015 MODY 4; 6-10 Maturity-Onset Diabetes of the Young (MODY)
P357-A2 Vs. 06 13-04-2017 MODY 4; 6-10 Maturity-Onset Diabetes of the Young (MODY)
P357-A3 Vs. 07 13-02-2018 MODY 4; 6-10 Maturity-Onset Diabetes of the Young (MODY)
Vs. 01
29-06-2011
4p, 5p telomeres and 13q,14q centromere regions Subtelomeric screening
Vs. 05
10-12-2015
4p, 5p telomeres and 13q,14q centromere regions Subtelomeric screening
Vs. 06
12-01-2017
4p, 5p telomeres and 13q,14q centromere regions Subtelomeric screening
Vs. 01
07-09-2010
1p36.22 Ehlers Danlos syndrome type VI
Vs. 02
15-02-2012
1p36.22 Ehlers Danlos syndrome type VI
Vs. 04
12-07-2013
1p36.22 Ehlers Danlos syndrome type VI
Vs. 05
10-02-2016
1p36.22 Ehlers Danlos syndrome type VI